These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12769641)

  • 1. Observations on the use of the avian chorioallantoic membrane (CAM) model in investigations into angiogenesis.
    Richardson M; Singh G
    Curr Drug Targets Cardiovasc Haematol Disord; 2003 Jun; 3(2):155-85. PubMed ID: 12769641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chorioallantoic membrane capillary bed: a useful target for studying angiogenesis and anti-angiogenesis in vivo.
    Ribatti D; Nico B; Vacca A; Roncali L; Burri PH; Djonov V
    Anat Rec; 2001 Dec; 264(4):317-24. PubMed ID: 11745087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chick embryo chorioallantoic membrane (CAM) assay.
    Ribatti D
    Reprod Toxicol; 2017 Jun; 70():97-101. PubMed ID: 27832950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chick embryo chorioallantoic membrane as a model for in vivo research on angiogenesis.
    Ribatti D; Vacca A; Roncali L; Dammacco F
    Int J Dev Biol; 1996 Dec; 40(6):1189-97. PubMed ID: 9032025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of anti-angiogenesis using the capillaries of the chick chorioallantoic membrane demonstrates that the effect of human angiostatin is age-dependent.
    Seidlitz E; Korbie D; Marien L; Richardson M; Singh G
    Microvasc Res; 2004 Mar; 67(2):105-16. PubMed ID: 15020201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of an in ovo chick embryo yolk sac membrane (YSM) assay for pilot screening of potential angiogenic and anti-angiogenic agents.
    As MN; Deshpande R; Kale VP; Bhonde RR; Datar SP
    Cell Biol Int; 2018 Nov; 42(11):1474-1483. PubMed ID: 30136736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capillary plexus development in the day five to day six chick chorioallantoic membrane is inhibited by cytochalasin D and suramin.
    Melkonian G; Munoz N; Chung J; Tong C; Marr R; Talbot P
    J Exp Zool; 2002 Feb; 292(3):241-54. PubMed ID: 11857458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chick embryo chorioallantoic membrane as a model system for the study of tumor angiogenesis, invasion and development of anti-angiogenic agents.
    Tufan AC; Satiroglu-Tufan NL
    Curr Cancer Drug Targets; 2005 Jun; 5(4):249-66. PubMed ID: 15975046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chick embryo chorioallantoic membrane (CAM). A multifaceted experimental model.
    Ribatti D
    Mech Dev; 2016 Aug; 141():70-77. PubMed ID: 27178379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New model for the study of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane: the gelatin sponge/chorioallantoic membrane assay.
    Ribatti D; Gualandris A; Bastaki M; Vacca A; Iurlaro M; Roncali L; Presta M
    J Vasc Res; 1997; 34(6):455-63. PubMed ID: 9425998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-angiogenic properties of myo-inositol trispyrophosphate in ovo and growth reduction of implanted glioma.
    Sihn G; Walter T; Klein JC; Queguiner I; Iwao H; Nicolau C; Lehn JM; Corvol P; Gasc JM
    FEBS Lett; 2007 Mar; 581(5):962-6. PubMed ID: 17316624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-angiogenic activity of a homoisoflavanone from Cremastra appendiculata.
    Shim JS; Kim JH; Lee J; Kim SN; Kwon HJ
    Planta Med; 2004 Feb; 70(2):171-3. PubMed ID: 14994197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel angiogenesis model for screening anti-angiogenic compounds: the chorioallantoic membrane/feather bud assay.
    Chen H; Wang CS; Li M; Sanchez E; Li J; Berenson A; Wirtschafter E; Wang J; Shen J; Li Z; Bonavida B; Berenson JR
    Int J Oncol; 2010 Jul; 37(1):71-9. PubMed ID: 20514398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel function of ascorbic acid as an angiostatic factor.
    Ashino H; Shimamura M; Nakajima H; Dombou M; Kawanaka S; Oikawa T; Iwaguchi T; Kawashima S
    Angiogenesis; 2003; 6(4):259-69. PubMed ID: 15166494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chick embryo and its chorioallantoic membrane (CAM) for the in vivo evaluation of drug delivery systems.
    Vargas A; Zeisser-Labouèbe M; Lange N; Gurny R; Delie F
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1162-76. PubMed ID: 17870202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of fibroblast growth factor-2 in the vascularization of the chick embryo chorioallantoic membrane.
    Ribatti D; Presta M
    J Cell Mol Med; 2002; 6(3):439-46. PubMed ID: 12417062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated delivery of fibroblast growth factor-2 and vascular endothelial growth factor onto the chick chorioallantoic membrane: endothelial fenestration and angiogenesis.
    Ribatti D; Nico B; Morbidelli L; Donnini S; Ziche M; Vacca A; Roncali L; Presta M
    J Vasc Res; 2001; 38(4):389-97. PubMed ID: 11455210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neridronate inhibits angiogenesis in vitro and in vivo.
    Ribatti D; Nico B; Mangieri D; Maruotti N; Longo V; Vacca A; Cantatore FP
    Clin Rheumatol; 2007 Jul; 26(7):1094-8. PubMed ID: 17106617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical appraisal of the chorioallantoic membrane model for studying angiogenesis in preclinical research.
    Shekatkar M; Kheur S; Deshpande S; Sakhare S; Sanap A; Kheur M; Bhonde R
    Mol Biol Rep; 2024 Sep; 51(1):1026. PubMed ID: 39340708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Processing of fluorescence angiograms for the quantification of vascular effects induced by anti-angiogenic agents in the CAM model.
    Nowak-Sliwinska P; Ballini JP; Wagnières G; van den Bergh H
    Microvasc Res; 2010 Jan; 79(1):21-8. PubMed ID: 19857502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.